
Today on Pharmaceutical Processing
Kincell Bio to expand North Carolina manufacturing site
Kincell Bio announced that it made a significant strategic investment in the expansion of its Research Triangle Park, North Carolina, facility. The contract development and manufacturing organization (CDMO) supports autologous and allogenic cell therapy programs. It expects the new expansion to support clients as they advance from late-stage clinical CMC development through commercialization and post-approval…Trelleborg exhibits single-use solutions for biopharma customers at Interphex
NEWS RELEASE: Trelleborg exhibits single-use solutions for biopharma customers at Interphex Plymouth, Minnesota – Trelleborg Medical Solutions will exhibit advanced solutions for biopharmaceutical, pharmaceutical and cell and gene therapy applications at Interphex in New York City, April 21 – 23, 2026, at Booth No. 2159. On display is Trelleborg’s BioPharmaPro portfolio, including solutions for bioprocessing,…Sponsored Content See More >
Regulatory See More >

Putting patients first in clinical trials
Clinical trials offer clinicians a unique opportunity to lead advances in medicine, granting access to cutting-edge therapies that address unmet patient needs. They are a cornerstone of clinical practice that enhance patient outcomes, particularly for those with complex or refractory cases who have exhausted standard treatment options. Clinicians understandably prioritize the well-being and interests of…

Confidently navigate the transition from bench to batch

FDA approves Merck’s Winrevair to treat pulmonary arterial hypertension

Report: Japan health authorities investigate Kobayashi Pharmaceutical factory after five deaths

Eicos Sciences’ FDA-approved Aurlumyn promises to drastically reduce frostbite amputations
Learn how to rapidly develop smart and sustainable engineering and production processes See More >

Personalized medicine: advanced technology is saving lives
The concept of a “batch size one” in pharmaceutical manufacturing is closer than ever. There are companies advancing cell therapies in which body cells are used to heal or support the individual patient. These cells are manipulated or edited to change certain biological characteristics before being transferred to the patient. Personalized medicine is truly about…
Facility See More >

MGS opens 300,000-square-foot Wisconsin facility to scale drug delivery device manufacturing
Healthcare CDMO manufacturer MGS has brought a 300,000 square foot drug delivery device manufacturing facility online in Richfield, Wisconsin. The move expands U.S. production capacity as demand for complex combination products strains available cleanroom capacity . FDA approved a record number of combination products in recent years, and the 505(b)(2) pathway has made device-drug combos…
Supply Chain See More >

Kincell Bio to expand North Carolina manufacturing site
Kincell Bio announced that it made a significant strategic investment in the expansion of its Research Triangle Park, North Carolina, facility. The contract development and manufacturing organization (CDMO) supports autologous and allogenic cell therapy programs. It expects the new expansion to support clients as they advance from late-stage clinical CMC development through commercialization and post-approval…
Recalls See More >

Report: Japan health authorities investigate Kobayashi Pharmaceutical factory after five deaths
Japanese health authorities searched a Kobayashi Pharmaceutical factory in Japan following reports of five deaths related to dietary supplements, Reuters reports. The plant inspection in western Japan is the second in recent days as health authorities inspected the company’s Osaka facility. In addition to the five reported deaths, there have been more than 100 hospitalizations…




































